Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 12 | $261,306 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 25 May 2023 19:24 | IGMS | IGM Biosciences Inc | TAKIMOTO CHRIS H | Chief Medical Officer | 23 May 2023 | Sale | 15 | 13.005 | 195 | D |
| 28 Nov 2022 20:31 | IGMS | IGM Biosciences Inc | TAKIMOTO CHRIS H | Chief Medical Officer | 23 Nov 2022 | Sale | 277 | 21.9914 | 6,092 | D |
| 01 Dec 2023 19:03 | IGMS | IGM Biosciences Inc | TAKIMOTO CHRIS H | Chief Medical Officer | 29 Nov 2023 | Sale | 1,180 | 6.213 | 7,331 | D |
| 18 Jun 2024 19:44 | IGMS | IGM Biosciences Inc | TAKIMOTO CHRIS H | CHIEF MEDICAL OFFICER | 14 Jun 2024 | Sale | 1,570 | 7.5753 | 11,893 | D |
| 28 Nov 2022 20:31 | IGMS | IGM Biosciences Inc | TAKIMOTO CHRIS H | Chief Medical Officer | 23 Nov 2022 | Sale | 600 | 21.3765 | 12,826 | D |
| 25 May 2023 19:24 | IGMS | IGM Biosciences Inc | TAKIMOTO CHRIS H | Chief Medical Officer | 23 May 2023 | Sale | 1,244 | 12.3005 | 15,302 | D |
| 17 Sep 2024 20:55 | IGMS | IGM Biosciences Inc | TAKIMOTO CHRIS H | CHIEF MEDICAL OFFICER | 13 Sep 2024 | Sale | 1,487 | 11.5388 | 17,158 | D |
| 15 Mar 2024 19:55 | IGMS | IGM Biosciences Inc | TAKIMOTO CHRIS H | CHIEF MEDICAL OFFICER | 14 Mar 2024 | Sale | 2,535 | 10.1705 | 25,782 | D |
| 15 Mar 2024 19:55 | IGMS | IGM Biosciences Inc | TAKIMOTO CHRIS H | CHIEF MEDICAL OFFICER | 13 Mar 2024 | Sale | 2,889 | 9.8752 | 28,529 | D |
| 16 Mar 2023 18:31 | IGMS | IGM Biosciences Inc | TAKIMOTO CHRIS H | Chief Medical Officer | 14 Mar 2023 | Sale | 1,768 | 18.732 | 33,118 | D |
| 20 Dec 2022 20:12 | IGMS | IGM Biosciences Inc | TAKIMOTO CHRIS H | Chief Medical Officer | 16 Dec 2022 | Sale | 1,938 | 19.3595 | 37,519 | D |
| 20 Dec 2022 20:12 | IGMS | IGM Biosciences Inc | TAKIMOTO CHRIS H | Chief Medical Officer | 16 Dec 2022 | Sale | 3,492 | 18.7746 | 65,561 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)